Company: BGLC
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001477932-25-008343
Chunk: 73

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 73
---
.

 48Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BioNexus Gene Lab Corp.  /s/ Su-Leng Tan LeeSu-Leng Tan Lee Chief Executive Officer (Principal Executive Officer)   /s/ Set Fui Chong Set Fui Chong Chief Financial Officer (Principal Financial and Accounting Officer) 

November 14, 2025

 49